Chris Ogden
Director of Finance/CFO at CYTOMX THERAPEUTICS, INC.
Net worth: 186 795 $ as of 31/03/2024
Profile
Chris Ogden is currently the Chief Financial & Accounting Officer at CytomX Therapeutics, Inc. He previously worked as the Chief Financial Officer-Diabetes Division at Eli Lilly & Co. and as the Chief Financial Officer & Treasurer at Lilly del Caribe, Inc. Mr. Ogden completed his undergraduate degree at Wabash College and holds an MBA from Harvard Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
19/03/2024 | 85,686 ( 0.13% ) | 186 795 $ | 31/03/2024 |
Chris Ogden active positions
Companies | Position | Start |
---|---|---|
CYTOMX THERAPEUTICS, INC. | Director of Finance/CFO | 21/09/2022 |
Former positions of Chris Ogden
Companies | Position | End |
---|---|---|
Lilly del Caribe, Inc.
Lilly del Caribe, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly del Caribe, Inc. is a Puerto Rican pharmaceutical manufacturing company. The private company is based in Mayagüez, Puerto Rico. | Director of Finance/CFO | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Training of Chris Ogden
Wabash College | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
CYTOMX THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Lilly del Caribe, Inc.
Lilly del Caribe, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly del Caribe, Inc. is a Puerto Rican pharmaceutical manufacturing company. The private company is based in Mayagüez, Puerto Rico. | Health Technology |
- Stock Market
- Insiders
- Chris Ogden